I opted out of writing for continuing medical education for many reasons. The main reason was the conflict of interest I was required to report to participate on advisory councils, panel discussions, and for many speaking opportunities outside of industry.
Another reason is the infrastructure that rewards conveniently finding gaps in disease states--and drug categories--with the deepest pockets.
If you have a strong interest in the science I would recommend NuSI Nutrition Science Initiative. No industry funding--pharma or food.
1. Utilization of ancillary services (diabetic counseling for diet, exercise regimens for weight loss and other therapeutic lifestyle changes for comorbid disease) are not applied routinely in caring for the diabetic patient despite guideline recommendations advocating these elements. This is due to lack of time, resource access and financial coverage.
2. Screening for, and treatment of, other comorbid conditions (hypertension, dyslipidemia) does not occur consistently.
3. Physicians do not take advantage of opportunities for managing at risk populations prior to the onset of clinical diabetes.
4. Patient registries and group medical appointments to identify and manage cohorts of diabetic patients within practices are still underutilized, despite government and insurer incentives to institute these.
But what do many CME stakeholders request? Data to support treating numbers, pharmaceuticals to tighten glycemic control, and other cost drivers of healthcare.